Open Access

[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer

  • Authors:
    • Yu-Hua Xu
    • Jian-Ren Tu
    • Tian-Tian Zhao
    • Shi-Guang Xie
    • Sheng-Bo Tang
  • View Affiliations

  • Published online on: January 14, 2019     https://doi.org/10.3892/ijo.2019.4686
  • Pages: 340-340
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2019
Volume 55 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu Y, Tu J, Zhao T, Xie S and Tang S: [Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer. Int J Oncol 55: 340-340, 2019
APA
Xu, Y., Tu, J., Zhao, T., Xie, S., & Tang, S. (2019). [Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer. International Journal of Oncology, 55, 340-340. https://doi.org/10.3892/ijo.2019.4686
MLA
Xu, Y., Tu, J., Zhao, T., Xie, S., Tang, S."[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer". International Journal of Oncology 55.1 (2019): 340-340.
Chicago
Xu, Y., Tu, J., Zhao, T., Xie, S., Tang, S."[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer". International Journal of Oncology 55, no. 1 (2019): 340-340. https://doi.org/10.3892/ijo.2019.4686